PDRNã¯ããµã±ã»ãã¹ãã粟補ããDNAæçãç®èã«å ¥ããæ³šå°æåã§ããæ€çŽ¢æ¬ã®ããµãŒã¢ã³æ³šå°ãã¯ãã®åç§°ãšãªãžã¥ã©ã³(Rejuran)ãã²ãšãŸãšãã«åŒã³ãŸãããæ¬æ¥åãåã補åã®ã©ãã«ã¯äž¡è ãåããŠèšããŸãã
3è¡ãŸãšã
PDRNã¯ãµã±ã»ãã¹ã®ç²ŸåDNAãã粟補ããæçã®æ··åç©ã§ãããäžè£œåã®åºæåã§ã¯ãªãæååã§ãã
æç®ã¯çްèã·ã°ãã«ãäœåãããDNAã®ææãäŸçµŠããäºæ¹åã§èª¬æããæž¬å®å¯Ÿè±¡ã¯äž»ã«åµå·ã»æœ°çã®å埩ã§ãã
ãªãžã¥ã©ã³äœ¿çšèª¬ææžã®äž»æåã¯PNïŒããªãã¯ã¬ãªãããããªãŠã ïŒã§ããã«ãŠã³ã»ãªã³ã°ã§ã¯ãæ¬æ¥ã®ãã€ã¢ã«ã«æžãããååãå ã«å°ããŸãã
PDRNãšã¯äœã
泚å°ã«å ¥ãã®ã¯ãã¿ã³ãã¯è³ªãåãé€ããããšç²Ÿè£œã»æ» èããæçã®æ··åç©ã§ããæ¿åºŠãç²Ÿè£œæ¹æ³ã䜿çšç®çã¯è£œåããšã«ç°ãªããŸãã
PDRNãšPNã¯ãéé¡ã®DNAããå§ãŸã£ãç¹ãå ±éã§ããå¥ã®æŠèгã¯ã2ã€ã®åç§°ãæç®ã®äžã§æ··çšãããŠãããšèšããŠããŸãã
| é ç® | å 容 |
|---|---|
| äœãå ¥ããã | ãµã±ã»ãã¹ã®ç²ŸåDNAãã粟補ããçãæçã§ãã |
| äœãæåŸ ããã | æç®ãå€ãæ±ã£ãŠããçµæã¯åµå·ã»æœ°çã®å埩ã§ãããªãžã¥ã©ã³ã®äœ¿çšèª¬ææžã¯ãæäººã®é¡ã®ããã®äžæçãªæ¹åã䜿çšç®çãšããŠèšããŠããŸãã |
| æœè¡åœæ¥ | æ¶æ¯ããå¿ èŠã«å¿ããŠéº»é ãããããã§ãèšç»ããå±€ã«å ¥ããŸããçŽåŸã¯èµ€ã¿ã»ããã¿ã»ãããåºãŸãã |
| å埩 | ãªãžã¥ã©ã³ã®å Žåãæœè¡åŸ12æéã¯åç²§ãæ§ãã2é±éã¯æ¥å ã»çŽ«å€ç·ã»ãµãŠãã®ããã«ç±ãé·ãåœããå Žæãé¿ããŸããPDRNãšã®ã¿èšããã補åã¯ããã®èª¬ææžã«æžãããææã«åŸããŸãã |
| è²»çšã®èãæ¹ | å ¥ããéãšåæ°ãéšäœãå€ãããšè²»çšãå€ãããŸãã |
PDRNãå ¥ããææ
PDRNïŒããªããªãã·ãªããã¯ã¬ãªããïŒã¯ãDNAãçãåã£ãŠéããæ³šå°ææã§ããæµ·å€ç ç©¶ããŒã ã®æŠèгã¯åæããµã±ã»ãã¹ã®ç²ŸåDNAãšèšããã¿ã³ãã¯è³ªãé€ãç²Ÿè£œã»æ» èéçšãçµãæçã®æ··åç©ã ãšèª¬æããŠããŸãããã®æŠèгã®è²¬ä»»èè ã¯PDRN補é å ããç ç©¶æ¯æŽãåããŠãããå ±èè ã®äžéšã¯é¢é£ç¹èš±ã®çºæè ãšããŠåŸããèšæ£èšèŒãããŸããã
åžè²©ã§PDRNãšåŒã°ããæ³šå°ã¯è€æ°ãããŸããæ¿åºŠã»ç²Ÿè£œæ¹æ³ã»äœ¿çšèª¬ææžã®äœ¿çšç®çã¯è£œåããšã«ç°ãªããããæååã®æšªã®è£œååãšäœ¿çšèª¬ææžãåããŠèŠãŸããã¹ãã³ããŒã¹ã¿ãŒã®äžã§ã®äœçœ®ã¥ãã¯ãã¹ãã³ããŒã¹ã¿ãŒã®çš®é¡æ¡å ã§ç¶ããŠã芧ããã ããŸãã
ç®èã§ç¥ãããŠããåã
åãæŠèŠ³ã¯ãPDRNãäºã€ã®æ¹åã«åããšæŽçããŠããŸããæçãåè§£ãããã«ã€ããŠçްè衚é¢ã®ã·ã°ãã«ãäœåããã现èãDNAãã€ãããšãã«äœ¿ãææãäŸçµŠããŸããå ±åãããŠããæ¹åã¯ãççãæããçµç¹ãåã³ä»ãåŽã§ãã
ãã®æç®ãåãäœçœ®ã¯åµå·ã»æœ°çã®å埩ã§ããç³å°¿ç æ§è¶³æœ°çã®ããã«æ²»ãã«ããå·ãæ±ã£ãæç« ãäžå¿ã§ããé¡ã®èçã»ãããèŠããšãããã®è³æã枬ã£ãã®ã¯å·ãéããéãã§ãã
ãªãžã¥ã©ã³ã®ã©ãã«ãšäžŠã¹ãŠã¿ããš
ãªãžã¥ã©ã³ã¯ãããªãµãŒã(PharmaResearch)ã®æ³šå°è£œåã§ãã䜿çšèª¬ææžã¯äž»æåãããªãã¯ã¬ãªãããããªãŠã ã䜿çšç®çãæäººé¡é¢ããã®äžæçãªæ¹åãšèšããŸããéåœã§ã¯çµç¹ãè£ãå»çæ©åšãšããŠèš±å¯ããã補åã§ãã
PDRNãšPNã¯ãããããéé¡DNAããåºçºãã倧ããªååæçã§ããå¥ã®æŠèгã¯ãäºã€ã®åç§°ãæç®ã§æ··çšããããšèšããŠããããã®è«æã®èè ã®ãã¡åççŽ æäŒæ¥ã«æå±ããè ãããŸããã«ãŠã³ã»ãªã³ã°ã§åãããç¹ã¯ãåŠè¡åãããæ¬æ¥ã®ãã€ã¢ã«ã«æžããã衚èšã§ãã
| é ç® | PDRN | ãªãžã¥ã©ã³ |
|---|---|---|
| äœãæãåŒã³åã | æåå | 補ååãäž»æåã¯PN |
| åæ | ãµã±ã»ãã¹ã®ç²ŸåDNA | éé¡DNAããåŸãããªãã¯ã¬ãªãããããªãŠã |
| è³æãåãçšé | åµå·ã»æœ°çã®å埩 | 䜿çšèª¬ææž: æäººã®é¡ã®ããã®äžæçãªæ¹å |
| ã«ãŠã³ã»ãªã³ã°ã§ç¢ºèªããè¡šèš | æ¬æ¥ã®ãã€ã¢ã«ã®æåå | ããŒã©ãŒã»ã¢ã€ã»Sãªã©ã®è£œåå |
⻠衚ã¯åç§°ãå¯Ÿç §ããããã®æ¡å ã§ãããªãžã¥ã©ã³ã®èš±å¯æèšãšçŠå¿ã¯ãªãžã¥ã©ã³ ããŒã©ãŒæ¡å ã§è£œååäœã«ç¶ããŸãã
PNã现èã»åç©ã§èŠãå®éšã¯ãå ç«çްèãçµãŠã³ã©ãŒã²ã³åæã«ã€ãªããçµè·¯ãå ±åããŸãããèè ã®ãã¡é¢é£äŒæ¥ã«æå±ããè ãããŸãããã®å®éšã®èгå¯å¯Ÿè±¡ã¯çްèãšåç©ã§ããæœè¡ããŒãžã¯ãªãžã¥ã©ã³æœè¡æ¡å ã§ãã
泚å°åœæ¥ãšãã®åŸ
PDRNãšåŒã°ããŠããªãžã¥ã©ã³ã§ããç®èã«éã§å ¥ããæ³šå°ã§ããéšäœã決ããæ¶æ¯ããããã§å¿ èŠãªã麻é ããæ±ºããŠãããå±€ã«å ¥ããŸããåœæ¥ã¯èµ€ã¿ã»ããã¿ã»ããã䌎ããŸãã
| 段é | åœæ¥ã«è¡ãããš |
|---|---|
| ç¢ºèª | æ¬æ¥ã®è£œååãæè¿ã®ãã£ã©ãŒãæçšè¬ãå ¥ããéšäœ |
| æºå | æ¶æ¯ããå¿ èŠãªãå±æéº»é |
| æ³šå ¥ | 決ããŠãããæ·±ãã«å ¥ããŸã |
| çŽåŸ | èµ€ã¿ã»ããã¿ã»ãããåç²§ã»ç±ã®åéæç¹ |
ãªãžã¥ã©ã³äœ¿çšèª¬ææžã¯ãæ³šå ¥éšäœã®çºèµ€ã»æµ®è «ã»çŽ æãããã¿ã»çã¿ãšãšãã«çããããšããããããããåå¿ã1é±éã»ã©ç¶ãå ŽåããããšèšããŸããéšäœã硬ããªã£ããè²ãå€ãã£ããããããšããããŸããæœè¡åŸ12æéã¯åç²§ãå éããããã®åŸ2é±éã¯æ¥å ã»çŽ«å€ç·ã»ãµãŠãã®ããã«ç±ã«é·ããããããç°å¢ãé¿ããŸããççã1é±ãè¶ ããå Žåã¯ãæœè¡ãåããæœèšã§èšºå¯ãåããŸãããªãžã¥ã©ã³ãåããæ¥ã®äœæã¯ãªãžã¥ã©ã³ã®çã¿ã»å埩æ¡å ã§ã芧ããã ããŸãã
PDRNãšã®ã¿èšããã補åã¯ã䜿çšèª¬ææžã補åããšã«ç°ãªããŸããåç²§ã»ãµãŠãã®åéæç¹ã¯ãæ¬æ¥ã®è£œåèª¬ææžãåºæºã«æžãçããŠãããŸããå ¥ããéã»åæ°ã»éšäœã«ãã£ãŠè²»çšã¯å€ãããæ±ºå®èŠå ã¯è²»çšæ¡å ã§ç¢ºèªã§ããŸãã
ã«ãŠã³ã»ãªã³ã°ã§ãã®ãŸãŸå°ãã質å
以äžããã®ãŸãŸå°ãããšãæ¬æ¥å ¥ããææãšé€å€å¯Ÿè±¡ã䜿çšèª¬ææžãšåãããèŠåããããŸãã
- â¡ æ¬æ¥ã®ãã€ã¢ã«ã«æžãããååãPDRN補åãããªãžã¥ã©ã³ã
- â¡ åŠåš ã»æä¹³äžã§ããããŸãã¯æªæå¹Žã§ããã
- â¡ éé¡DNAã»ããªãã¯ã¬ãªãããããªãŠã ã«éæãçµéšããããšãããã
- â¡ æ¶çé®çè¬ãè¡æ¶²ãããããã«ããè¬ãå ç«æå¶è¬ã䜿ã£ãŠããã
- â¡ æè¿ãã£ã©ãŒãå ¥ããéšäœããããŸç®èã«ææã»ççãããã
ãªãžã¥ã©ã³äœ¿çšèª¬ææžã®äœ¿çšé€å€ã«ã¯ãåžåãããªããã£ã©ãŒãå ¥ããéšäœãã¢ã¬ã«ã®ãŒæ§çŸæ£ã»èªå·±å ç«çŸæ£ãè¡ç®¡å 泚å°ãå«ãŸããŸãã該åœé ç®ãããã°ãä»ã®æ¹æ³ãæ€èšããŸããå ±éã®æ³šæã¯æœè¡ã®å®å šæ¡å ã§ç¶ããŠã芧ããã ããŸãã
ãããã質å
Q1. PDRN泚å°ã¯çãã§ããïŒ
éãå ¥ãããããã¯ããšããæãããããŸããå¿ èŠãªãå±æéº»é ãããŸããçŽåŸã®çã¿ãšã€ã£ã±ãã¯ãå ¥ããéšäœãšéã«ãã£ãŠå€ãããŸãã
Q2. äœååããŸããïŒ
åæ°ãšééã¯ãæ¬æ¥ã®è£œåãšéšäœã«åãããŠæ±ºããŸãããªãžã¥ã©ã³äœ¿çšèª¬ææžã¯å ¥ããéãç¯å²ã«å¿ããŠèª¿ç¯ããããèšããã ãã§ãé¡å šäœãäœåã§çµãããšããæ°åã¯çœ®ããŠããŸããã
Q3. ã©ã®ãããæç¶ããŸããïŒ
ãªãžã¥ã©ã³äœ¿çšèª¬ææžã¯äœ¿çšç®çãäžæçãªæ¹åã«éã£ãŠããŸããèšåºã§èŠãæéãè¶ ããé·æäœ¿çšã®å®å šæ§ã»æå¹æ§ã¯ç¢ºèªåã ãšèšãããŠããŸããæ¬¡ã®æœè¡æç¹ã¯çµéãèŠãŠæ±ºããŸãã
Q4. ä»ã®æœè¡ãšäžç·ã«åããŠãããã§ããïŒ
ãªãžã¥ã©ã³äœ¿çšèª¬ææžã¯ãæè¿ãã£ã©ãŒãå ¥ããéšäœãšåžåãããªããã£ã©ãŒãå ¥ããéšäœãé€å€ããŸããåãã«ãŠã³ã»ãªã³ã°ã§ä»ã®ã¹ãã³ããŒã¹ã¿ãŒåãåºãå Žåã¯ãæ¬æ¥å®éã«å ¥ããã»ããå ã«éžã³ãŸããææã®æ¯èŒã¯ãªãžã¥ã©ã³ãšãžã¥ãã«ãã¯(Juvelook)ã®æ¯èŒã§ã芧ããã ããŸãã
Q5. 誰ãé¿ããå¿ èŠããããŸããïŒ
ãªãžã¥ã©ã³äœ¿çšèª¬ææžã«åºã¥ã䜿çšé€å€ã¯åŠåš ã»æä¹³ãæªæå¹Žãææã»ççã®ããç®èãåœè©²æåãžã®éæãæ¶çé®çè¬ã»æååºè¬ã»å ç«æå¶è¬ã®äœ¿çšãã¢ã¬ã«ã®ãŒæ§çŸæ£ã»èªå·±å ç«çŸæ£ã§ããPDRNãšã®ã¿èšããã補åã¯ããã®è£œåã®äœ¿çšèª¬ææžã®é€å€äžèЧã«åŸããŸãã
çµæã»æç¶ã»é©åã®å¯åŠã¯ããäžäººãã²ãšãã®èç¶æ ã»å¹Žéœ¢ã»çæŽ»ç¿æ £ã«ãã£ãŠå·®ããããåãçµæããçŽæããããšã¯ã§ããŸããã
æœè¡ã«ã¯äžæçãªèµ€ã¿ã»ããã¿ãªã©ã®å¯åå¿ãçããå¯èœæ§ããããçŠå¿äºé ãããå ŽåããããŸãã®ã§ãäºåã«ãŠã³ã»ãªã³ã°ã§ã確èªãã ããã
æ¬èšäºã¯äžè¬çãªæ å ±ã®ãæ¡å ã§ãããåå¥ã®èšºçã«ä»£ãããã®ã§ã¯ãããŸããããèªèº«ã®ç¶æ ã«åããã蚺æã»æœè¡ã¯ã«ãŠã³ã»ãªã³ã°ã§ã確èªãã ããã
æ ¹æ è³æ
- Squadrito Fã»ãïŒ2017ïŒãFront Pharmacol: Pharmacological Activity and Clinical Use of PDRNïŒPMID 28491036ïŒ
- Marques Cã»ãïŒ2025ïŒãBiomolecules: From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs): Bridging the Gap Between Scientific Definitions, Molecular Insights, and Clinical Applications of Multifunctional BiomoleculesïŒPMID 39858543ïŒ
- Byun KAã»ãïŒ2025ïŒãInt J Mol Sci: Polynucleotides Enhance Collagen Synthesis via Modulating Phosphoenolpyruvate Carboxykinase 1 in Senescent Macrophages: Experimental EvidenceïŒPMID 40943641ïŒ
- PharmaResearchïŒãªãžã¥ã©ã³äœ¿çšèª¬ææžïŒ2024-12ïŒ
ããããŠèªã
çŸåšã®ç¶æ ã«åãæœè¡çžè«
çŸåšã®å¥åº·ç¶æ ãšéå»ã®æœè¡æŽã確èªããããã§ãæ€èšå¯èœãªéžæè¢ãšéçããæ¡å ããŸãã



